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Key Clinical Message
Clinical geneticists, neurologists, psychiatrists, and other healthcare providers
can learn from this case report that patients with a behavioral phenotype that
includes a mild learning disability may also require a thorough examination,
including brain MRI and whole-exome sequencing.
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Behavioral phenotype of genetic syndromes, corpus callosum hypogenesis,
L1CAM mutation, X-linked mental retardation.
Introduction
Mutations in the gene encoding L1 cell adhesion molecule
(L1CAM) are phenotypically characterized by X-linked
hydrocephalus (OMIM #307000) or—in milder cases—
corpus callosum agenesis or hypogenesis (OMIM
#304100) [1]. The variability in clinical presentation
reflects different functions of L1CAM. Hydrocephalus is a
very complex disorder. Mutations in L1 as a cell adhesion
molecule play a role in the pathogenesis of
hydrocephalus. The corpus callosum hypogenesis reflects
dysfunction as a neural recognition molecule through dis-
orders in axonal growth and guidance [2].
The L1CAM gene is located on the X chromosome at
Xq28 and is expressed primarily in the nervous system,
where it plays important roles in neuronal development,
including the guidance of neurite outgrowth, neuronal
cell migration, axon bundling, synaptogenesis, myelina-
tion, neuronal cell survival, and long-term potentiation
[3].
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The patients with hydrocephalus have a worse progno-
sis [4]. This is in agreement with recent evidence that
some forms of hydrocephalus and the inborn neurological
impairment are inseparable phenomena. This is because
both fetal onset hydrocephalus and abnormal neurogene-
sis have a common origin: a primary pathology of the
embryonic ventricular zone, involving neural stem cells
and multiciliated ependymal cells. Junctional failure and
loss of neural stem cells underpin the etiology of neuronal
migration defects at specific regions of brain. Thus, neo-
nates are born with a neurodevelopmental deficit that
derivative surgery cannot solve [5, 6].
Here, we report a patient with a generally mild physical
presentation but with a more distinct behavioral phenotype.
Clinical Description
The proband (referred to here as “Patient A”) is a 56-
year-old man born in a family with two brothers from
nonconsanguineous healthy parents. One of his two
brothers has a learning disability of unknown severity; the
other does not. Their mother had 14 siblings; three of her
brothers had a learning disability. Patient A’s parents died
around the age of 75. Patient A’s daughter developed epi-
lepsy at the age of 6; she initially experienced absence sei-
zures, and later developed grand mal seizures. For the
past 2 years, she has taken valproate and has been sei-
zure-free. Patient A’s son is healthy.
The proband sought help from professional caregivers
due to anxiety and depression following several major life
events. He was fired 10 years ago and was unable to find
a new job until he found employment at a sheltered
workplace as a postal employee. In addition, he experi-
enced the deaths of his parents and his parents-in-law.
Patient A also experienced difficulty remembering essen-
tial information during work and at home. He lives with
his wife and two adult children in the center of a large
city in the Netherlands, where he was born. The patient
requested a psychological and neurological evaluation
because he experienced a subdural hematoma with cere-
bral contusion following an unexpected fall when he was
28 years of age. Although the subdural hematoma was
treated, he wondered whether his recent complaints were
related to this earlier injury.
A thorough patient history revealed a mild learning
disability that was present since his earliest memories. At
10 years of age, he set fire to his family’s house, after
which he was removed from his home by child services.
He also switched to a school for children with mild learn-
ing disabilities and behavioral difficulties. At 16 years of
age, he experienced his first epileptic seizure and was trea-
ted with antiepileptic drugs. It is unclear whether the
accident at 28 years of age, which led to the subdural
hematoma, was caused by an epileptic seizure, as he fre-
quently experienced unexpected falls.
The results of a psychological examination revealed
overall difficulties with cognitive functioning, including
impaired memory, attention, and executive functions. The
patient’s clinical history and test results revealed that psy-
chological problems appeared at an early age, leading to
social, emotional, and behavioral problems. Therefore,
combined with his intellectual challenges, the patient
lacked sufficient opportunities to learn the appropriate
skills needed to cope during complex, stressful situations.
These developmental issues, limited coping skills, and
limited opportunities to express himself emotionally likely
predisposed the patient to develop depression, particularly
when experiencing stress due to a lack of structure in his
daily life, thereby having a strongly disrupting effect on
daily functioning and activities (Table 1).
Physical examination revealed a healthy adult male
with the following parameters: height, 177.5 cm (1 SD);
weight, 77.6 kg (+1.3 SD); occipito-frontal circumference,
57.3 cm (0.33 SD); left ear length, 7.4 cm (75th–97th
percentile); left hand length, 21.1 cm (above the 97th per-
centile); and mildly adducted thumbs. The patient pre-
sented with no gait abnormalities, and a neurological
examination was unremarkable.
In addition, an MRI examination of the brain revealed
hypogenesis of the corpus callosum, particularly in the
splenium (Fig. 1), as well as signs of prior traumatic inju-
ries to the right frontal brain parenchyma and mild,
slightly asymmetric dilatation of the lateral ventricles due
to underdevelopment and/or loss of white matter (Fig. 2);
the loss of white matter in the right hemisphere may have
been due in part to the prior traumatic brain injury.
A genetic examination was also performed. SNP array
analysis revealed a normal male karyotype. Whole-exome
sequencing (WES) was performed essentially as reported
previously [7]. Exome capture was performed using the
Agilent SureSelect Human All Exon v4 enrichment kit
(Agilent Technologies, Santa Clara, CA), and WES was
performed using the Illumina HiSeq platform (BGI,
Copenhagen, Denmark). Data were analyzed using the
BWA (read alignment) and GATK (variant calling)
software packages. Variants were annotated using an in-
house-developed pipeline and prioritized using an in-
house-designed “variant interface” with manual curation.
Putative causative variants were confirmed by Sanger
sequencing. WES revealed the missense mutation
c.998C>T (p.Pro333Leu) in the proband’s L1CAM gene
(NM_000425.3). Segregation analysis revealed that the
same mutation was present in the proband’s brother with
a learning disability; in contrast, the proband’s other
brother—who did not have developmental abnormalities
—did not carry this variant. It was not possible to obtain
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genetic material for testing the proband’s deceased
mother —who would have been an obligate carrier of the
variant—or her brothers with mental disability.
This missense variant causes the substitution of a highly
conserved nucleotide (phyloP: 5.29) and amino acid resi-
due in the immunoglobulin-like domain of the L1CAM
gene and protein, respectively. This mutation has not been
described previously in any SNP database, including dbSNP
and the EXAC database (http://exac.broadinstitute.org/);
moreover, several mutation prediction tools predict that
this variant is likely to be pathogenic.
Discussion
In this clinical report, we present a male patient with a
novel, putative pathogenic variant in the L1CAM gene.
This variant affects the structure of the fourth
immunoglobulin-like domain in the protein, as Pro333 is
believed to be one of the key residues required for proper
folding of this domain [8]. Therefore, this variant likely
disrupts interactions between both L1-L1 proteins and
L1-non-L1 proteins, interactions that are important for
protein function. Interestingly, a different variant in the
same amino acid (p.Pro333Arg) was described in a
patient with X-linked hydrocephalus; this patient died
before the age of 1 [4]. As we mentioned before, some
forms of hydrocephalus are not just ventriculomegaly, but
the tip of the iceberg of a complex neurodevelopmental
disorder [5, 6].
In the family reported here, the c.998C>T variant was
present in both the proband and his affected brother, but
Table 1. Psychological test results of Patient A (measured April, 2013).
Domain Results Test(s)
Intellectual functioning Verbal IQ: 68; Performance IQ: 70; Full Scale IQ: 69;
Verbal Comprehension Index 66; Perceptual
Organization Index: 63; Working Memory Index: 88;
Processing Speed Index: 76
Wechsler Adult Intelligence Scale—Third Edition,
Dutch version (WAIS-III-NL) [12]
Attention and working memory Below the mean, but not significantly impaired
compared with cognitive functioning.
Trail Making Test (TMT) [13]; Test of Everyday
Attention for Children (TEA-Ch) [14, 15]; Stroop
Color Word Test (STROOP) [16]; D2 Test of
Attention (D2) [17, 18]
Executive functioning Significantly decreased in all domains, including
initiative, motivation, planning, and control/evaluation
of behavior, flexibility and problem solving. The
subject made perseverative mistakes.
Behavioral Assessment of the Dysexecutive
Syndrome (BADS-NL) [19]; Word Fluency Test
(WFT); Figure Fluency Test (FFT) [20]
Visual and visuo-motor ability Decreased; indicative of neurological syndrome. WAIS-III-NL, RCFT [21]; Hooper Visual Organization
Test (VOT) [22]
Gross and fine motor function Gross motor function was normal; fine motor function
was decreased slightly; coordination tasks and
switching of functions were decreased considerably.
Test of manual dexterity and bimanual
coordination: Purdue Pegboard [23, 24]
Personality and social functioning Characterized by emotional disturbances which were
not overtly evident due to introvert coping. This led to
depression, tense feelings, and feelings of inferiority
and hopelessness. Social functioning was
characterized by shyness, reduced self-confidence,
reduced confidence in others, and impaired
communication.
Clinical interview with the proband and his wife;
Dutch Personality Inventory (Nederlandse
Persoonlijkheid-Vragenlijst (NPV-2) [25]).
Figure 1. Midsagittal T1 SE image of the brain of Patient A
illustrating the hypogenesis of the corpus callosum, in particular the
splenium of the corpus callosum (arrow).
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not in the proband’s unaffected brother. Both the patient
and his affected brother presented with a rather mild clin-
ical course. In most families with L1 syndrome, the
affected boys die before, during, or soon after birth; how-
ever, both interfamily variability and intrafamily variabil-
ity have been reported [9]. Basel-Vanagaite et al.
described two half-brothers who had a mutation in the
L1CAM gene and a hypoplastic corpus callosum, but no
other characteristics of L1 syndrome [1]. Epilepsy has also
been reported in a minority of patients with L1 syndrome
[10].
In our study, the proband presented with a hypoplastic
corpus callosum and some minor clinical features of L1
syndrome. In this case, the patient’s behavioral phenotype
appeared to be more severe and distinct than his physical
phenotype. Because social delays and behavioral abnor-
malities have been described in patients with corpus callo-
sum abnormalities, an integrative examination of these
functions should be included in the diagnostic protocol
[11].
The value to this family from obtaining this diag-
nosis should not be underestimated. For example, sev-
eral family members are now comforted by the fact
that they—and their children—do not have an
increased risk of recurrence. In addition, other family
members—particularly the proband’s adolescent
daughter—now have the opportunity to seek clinical
genetic advice when deciding whether to have chil-
dren. Moreover, this family has learned that they
should not expect the proband to achieve a higher
level of functioning, and they have learned not to
overestimate his abilities as either a husband or a
father. After receiving this genetic diagnosis, his pri-
mary clinical goal—namely to help resolve his depres-
sive symptoms—has waned.
Based on these findings, clinicians should be aware of
the value of performing neuroimaging in persons with
developmental disabilities, and they should offer their
patients the opportunity to seek an etiological diagnosis,
including genetic testing. Psychiatrists—particularly those
who work in the field of intellectual disabilities/learning
disabilities—should be made aware of the options avail-
able regarding diagnostic procedures based on clinical
genetics and neuroimaging. These procedures can provide
evidence-based assistance to patients and their families,
including preventive management, thereby improving
quality of life.
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Figure 2. Axial T2 Flair image of the brain of Patient A shows the
post-traumatic loss of tissue in the right frontal lobe (arrow) with
surrounding gliosis (scar tissue, arrowheads). There is a mild and
slightly asymmetric dilatation of the lateral ventricles (asterisks).
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